| Year |
Citation |
Score |
| 2015 |
Barmada SJ, Ju S, Arjun A, Batarse A, Archbold HC, Peisach D, Li X, Zhang Y, Tank EMH, Qiu H, Huang EJ, Ringe D, Petsko GA, Finkbeiner S. Amelioration of toxicity in neuronal models of amyotrophic lateral sclerosis by hUPF1 Proceedings of the National Academy of Sciences of the United States of America. 112: 7821-7826. DOI: 10.1073/pnas.1509744112 |
0.92 |
|
| 2014 |
Barmada SJ, Serio A, Arjun A, Bilican B, Daub A, Ando DM, Tsvetkov A, Pleiss M, Li X, Peisach D, Shaw C, Chandran S, Finkbeiner S. Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models. Nature Chemical Biology. 10: 677-85. PMID 24974230 DOI: 10.1038/nchembio.1563 |
0.92 |
|
| 2014 |
Qiu H, Lee S, Shang Y, Wang WY, Au KF, Kamiya S, Barmada SJ, Finkbeiner S, Lui H, Carlton CE, Tang AA, Oldham MC, Wang H, Shorter J, Filiano AJ, et al. ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. The Journal of Clinical Investigation. 124: 981-99. PMID 24509083 DOI: 10.1172/JCI72723 |
0.92 |
|
| 2013 |
Bilican B, Serio A, Barmada SJ, Nishimura AL, Sullivan GJ, Carrasco M, Phatnani HP, Puddifoot CA, Story D, Fletcher J, Park IH, Friedman BA, Daley GQ, Wyllie DJ, Hardingham GE, et al. Comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells". Science Translational Medicine. 5: 188le2. PMID 23740897 DOI: 10.1126/scitranslmed.3005065 |
0.92 |
|
| 2013 |
Serio A, Bilican B, Barmada SJ, Ando DM, Zhao C, Siller R, Burr K, Haghi G, Story D, Nishimura AL, Carrasco MA, Phatnani HP, Shum C, Wilmut I, Maniatis T, et al. Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proceedings of the National Academy of Sciences of the United States of America. 110: 4697-702. PMID 23401527 DOI: 10.1073/pnas.1300398110 |
0.92 |
|
| 2012 |
Armakola M, Higgins MJ, Figley MD, Barmada SJ, Scarborough EA, Diaz Z, Fang X, Shorter J, Krogan NJ, Finkbeiner S, Farese RV, Gitler AD. Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models. Nature Genetics. 44: 1302-9. PMID 23104007 DOI: 10.1038/ng.2434 |
0.92 |
|
| 2012 |
Martens LH, Zhang J, Barmada SJ, Zhou P, Kamiya S, Sun B, Min SW, Gan L, Finkbeiner S, Huang EJ, Farese RV. Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury. The Journal of Clinical Investigation. 122: 3955-9. PMID 23041626 DOI: 10.1172/JCI63113 |
0.92 |
|
| 2012 |
Waung MW, Grossman AW, Barmada SJ, Josephson SA, Dillon WP, Ralph JW. Pearls & oy-sters: the use of CT venography in Hirayama disease. Neurology. 79: e38-40. PMID 22851722 DOI: 10.1212/WNL.0b013e3182616fe8 |
0.92 |
|
| 2012 |
Bilican B, Serio A, Barmada SJ, Nishimura AL, Sullivan GJ, Carrasco M, Phatnani HP, Puddifoot CA, Story D, Fletcher J, Park IH, Friedman BA, Daley GQ, Wyllie DJ, Hardingham GE, et al. Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proceedings of the National Academy of Sciences of the United States of America. 109: 5803-8. PMID 22451909 DOI: 10.1073/pnas.1202922109 |
0.92 |
|
| 2010 |
Barmada SJ, Finkbeiner S. Pathogenic TARDBP mutations in amyotrophic lateral sclerosis and frontotemporal dementia: disease-associated pathways. Reviews in the Neurosciences. 21: 251-72. PMID 21086759 |
0.92 |
|
| 2010 |
Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, Finkbeiner S. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 639-49. PMID 20071528 DOI: 10.1523/JNEUROSCI.4988-09.2010 |
0.92 |
|
| 2009 |
Jeffrey M, Goodsir C, McGovern G, Barmada SJ, Medrano AZ, Harris DA. Prion protein with an insertional mutation accumulates on axonal and dendritic plasmalemma and is associated with distinctive ultrastructural changes. The American Journal of Pathology. 175: 1208-17. PMID 19700753 DOI: 10.2353/ajpath.2009.090125 |
0.92 |
|
| 2008 |
Medrano AZ, Barmada SJ, Biasini E, Harris DA. GFP-tagged mutant prion protein forms intra-axonal aggregates in transgenic mice. Neurobiology of Disease. 31: 20-32. PMID 18514536 DOI: 10.1016/j.nbd.2008.03.006 |
0.92 |
|
| 2007 |
Li A, Piccardo P, Barmada SJ, Ghetti B, Harris DA. Prion protein with an octapeptide insertion has impaired neuroprotective activity in transgenic mice. The Embo Journal. 26: 2777-85. PMID 17510630 DOI: 10.1038/sj.emboj.7601726 |
0.92 |
|
| 2007 |
Szewczyk NJ, Peterson BK, Barmada SJ, Parkinson LP, Jacobson LA. Opposed growth factor signals control protein degradation in muscles of Caenorhabditis elegans. The Embo Journal. 26: 935-43. PMID 17290229 DOI: 10.1038/sj.emboj.7601540 |
0.92 |
|
| 2007 |
Li A, Barmada SJ, Roth KA, Harris DA. N-terminally deleted forms of the prion protein activate both Bax-dependent and Bax-independent neurotoxic pathways. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 852-9. PMID 17251426 DOI: 10.1523/JNEUROSCI.4244-06.2007 |
0.92 |
|
| 2005 |
Barmada SJ, Harris DA. Visualization of prion infection in transgenic mice expressing green fluorescent protein-tagged prion protein. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 5824-32. PMID 15958749 DOI: 10.1523/JNEUROSCI.1192-05.2005 |
0.92 |
|
| 2000 |
Szewczyk NJ, Hartman JJ, Barmada SJ, Jacobson LA. Genetic defects in acetylcholine signalling promote protein degradation in muscle cells of Caenorhabditis elegans. Journal of Cell Science. 113: 2003-10. PMID 10806111 |
0.92 |
|
| 1997 |
Zdinak LA, Greenberg IB, Szewczyk NJ, Barmada SJ, Cardamone-Rayner M, Hartman JJ, Jacobson LA. Transgene-coded chimeric proteins as reporters of intracellular proteolysis: starvation-induced catabolism of a lacZ fusion protein in muscle cells of Caenorhabditis elegans. Journal of Cellular Biochemistry. 67: 143-53. PMID 9328848 DOI: 10.1002/(SICI)1097-4644(19971001)67:1<143::AID-JCB15>3.0.CO;2-I |
0.92 |
|
| Show low-probability matches. |